Australia | Part 1: Patenting orphan drugs
Collectively, rare diseases impact approximately 8% of the Australian population, or around 2 million people. Orphan drugs are pharmaceutical products developed to treat rare diseases, however with each drug...
Collectively, rare diseases impact approximately 8% of the Australian population, or around 2 million people. Orphan drugs are pharmaceutical...
Read More
Patent Prosecution Highway Programme Between IPOS and EPO
The Intellectual Property Office of Singapore (IPOS) has announced the commencement of a Patent Prosecution Highway (PPH) pilot programme with the European Patent Office. The pilot programme commenced on...
The Intellectual Property Office of Singapore (IPOS) has announced the commencement of a Patent Prosecution Highway (PPH) pilot programme...
Read More